Other
IVGTT
IVGTT is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Glucose Metabolism in Pregnant Women With a History of Bariatric Surgery, as Well as Three to Six Months After Delivery.
NCT03190148
completednot_applicable
Bed Rest, Alternate Daily Fasting and Incretin Effect
NCT02134860
completednot_applicable
Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
NCT01347801
Clinical Trials (3)
Showing 3 of 3 trials
NCT03190148Not Applicable
Glucose Metabolism in Pregnant Women With a History of Bariatric Surgery, as Well as Three to Six Months After Delivery.
NCT02134860Not Applicable
Bed Rest, Alternate Daily Fasting and Incretin Effect
NCT01347801Not Applicable
Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3